WHO Global Summit on Traditional Medicine Commences in New Delhi (See 'Corp Brief') MoS delivers national statement at UN on outcomes of World Summit on the Information Society (See 'Corp Brief') PM MITRA Parks anchored in 5F vision generating huge investment interest (See 'Corp Brief') IPR - While assessing 'prior art', mere similarity is insufficient and visual distinction matters, and for prior art to invalidate design, it must be clearly established and comparable in relevant features: HC (See 'Legal Desk') Steps taken to strengthen security of cyber ecosystem (See 'Corp Brief') ICG Ship Sarthak makes Strategic Port Call at Chabahar (See 'Corp Brief') IPR - On being satisfied that brand or mark has acquired status which is well known, there ought to be order directing that no individuals should be allowed to register UPI Ids or VPAs with said brand names: HC (See 'Legal Desk') CCI okays acquisition of paper & pulp manufacturing business of ABREL by ITC Ltd (See 'Corp Brief') CCI okays acquisition of equity stake in Logisteed Holdings, Ltd. by Japan Post Co., Ltd. (See 'Corp Brief') CCI nod to proposed combination involving acquisition of minority shareholding in DCX Global Limited by Coinbase Global Inc. (See 'Corp Brief') IBC - Compromise between bank and co-guarantor did not extinguish liability of other guarantors, who issued separate, enforceable undertakings: HC (See 'Legal Desk') Motor insurance complaints fall from 26.18% in FY 2023-24 to 24.8% in FY 2024-25 (See 'Corp Brief') DPIIT launches District Business Reform Action Plan (See 'Corp Brief') MoHUA holds Preparatory Workshop to Chart Roadmap for Clean Himalayan Hill Cities (See 'Corp Brief') IPR - Visage had made out strong prima facie case for protection; Freecia is restrained from copying packaging layout, ingredient descriptions, usage steps or using mark 'DERMOMELAN' until final disposal of suit: HC (See 'Legal Desk') BHEL hands over dividend cheque of Rs 109 cr to GoI (See 'Corp Brief') NESTS is organising 2nd EMRS Principals' Conclave on Effective Management of Schools (See 'Corp Brief') Govt has focused on further decriminalization to enhance Ease of Living and EODB: MoS (See 'Corp Brief') A&C - Post-insolvency commencement date claims that are not made part of Resolution Plan are not arbitrable: HC (See 'Legal Desk') Relentless execution transformed India's Energy Sector: Goyal (See 'Corp Brief') Over 8.45 crore subscribers enrolled under APY as on 30th Nov: MoS (See 'Corp Brief') Misc - It is duty of litigant to keep track of his own case, and he cannot shift entire burden on to shoulders of his counsel: HC (See 'Legal Desk') Rail Electrification boosts Efficiency, Cuts Diesel Consumption and Sets Global Benchmark (See 'Corp Brief') 53rd Edition of Fit India Sundays on Cycle dedicated to Vijay Diwas held in Goa (See 'Corp Brief') Scindia unveils 25-Foot Statue of Chhatrapati Shivaji Maharaj in Karnataka (See 'Corp Brief') PMLA - Secured creditor is entitled to stake its claim before liquidator as per Section 53 of IBC, qua immovable property, and same can be disposed of by liquidator as per law: SAFEMA (See 'Legal Desk') Mizoram gets its First Rail-Carried Cars (See 'Corp Brief') Minister highlighting rich craft traditions and their relevance to contemporary living (See 'Corp Brief') Scindia unveils Commemorative Postage Stamp on 150th anniversary of Bombay Gymkhana (See 'Corp Brief') SEBI - Request for unfreezing bank accounts based merely on value of securities in demat accounts, in absence of compliance with direction of Interim Order of depositing impounded gains in Escrow Account, cannot be accepted: SEBI (See 'Legal Desk')

Print

Glenmark's Swiss arm gets nod to market Ryaltris nasal spray in Russia

Published: Feb 22, 2021

By TIOLCORPLAWS News Service

NEW DELHI, FEB 22, 2021: GLENMARK Pharmaceuticals on Monday said its Swiss subsidiary, Glenmark Specialty, has received marketing approval from Russian health regulators for its fixed-dose combination nasal spray, Ryaltris.

Ryaltris is indicated for symptomatic treatment of seasonal and perennial allergic rhinitis, like stuffy and runny nose, nasal itching, sneezing, as well as irritated eyes, in adults and children over 12 years of age.

"Glenmark has built strong capabilities in the area of respiratory medicine and is among the leading players in this therapy area across several markets globally. Russia is one of the key markets for us and we are consistently looking to expand our product portfolio," said Csaba Kantor, Senior Vice President - Russia and CIS region, Glenmark.

In Russia, allergic rhinitis affects 10-20 per cent of the population on average, with certain regions having a higher prevalence rate of 18-38 per cent.

"Glenmark has a strong established presence in Russia for over 30 years, which will enable us to lead the commercialization of this product in the country. We look forward to being able to make this innovative product available to patients in Russia as soon as possible," Mr Kantor added.

The company estimated that Ryaltris will be available to patients in Russia by the first quarter of 2021-22.

TIOL CORP SEARCH

TIOL GROUP WEBSITES

taxindiaonline
taxindiainternational
tioltube
TKF
TIOLawards
A TIOL Website. Copyright © 2025 TIOLcorplaws.com All rights reserved.